4.The influence of pituitary volume on the growth response in growth hormone-treated children with growth hormone deficiency or idiopathic short stature
Jun Suk OH ; Beomseok SOHN ; Youngha CHOI ; Kyungchul SONG ; Junghwan SUH ; Ahreum KWON ; Ho-Seong KIM
Annals of Pediatric Endocrinology & Metabolism 2024;29(2):95-101
Purpose:
Magnetic resonance imaging (MRI) can be used for assessing the morphology of the pituitary gland in children with short stature. The purposes of this study were: (1) to determine if pituitary volume (PV) can distinguish patients with growth hormone (GH) deficiency from those with idiopathic short stature (ISS), (2) to validate an association between PV and severity of GH deficiency, and (3) to compare PV between good and poor response groups in children with GH deficiency or ISS after 1 year of treatment.
Methods:
Data were collected from the medical records of 152 children with GH deficiency or ISS who underwent GH stimulation test, sella MRI, and GH treatment for at least 1 year. Estimated PVs were calculated using the formula of an ellipsoid. We compared the PVs in patients with GH deficiency with those of patients with ISS. In addition, we assessed the association between PV and severity of GH deficiency, and we assessed growth response after treatment.
Results:
No difference was observed in PV between patients with GH deficiency and those with ISS. The severity of the GH deficiency seemed to be associated with PV (P=0.082), and the height of the pituitary gland was associated with severity of GH deficiency (P<0.005). The PV in the good response group was less than that of the poor response group in patients with GH deficiency (P<0.005), and PV showed no association with responsiveness to GH treatment in patients with ISS (P=0.073).
Conclusion
The measurement of PV cannot be used for differential diagnosis between GH deficiency and ISS. In patients with GH deficiency, PV tended to be smaller as the severity of GH deficiency increased, but the difference was not significant. PV may be a good response predictor for GH treatment. Further studies, including a radiomics-based approach, will be helpful in elucidating the clinical implications of pituitary morphology in patients with short stature.
5.Insulin resistance and bone age advancement in girls with central precocious puberty.
Jin Ho HUR ; Sora PARK ; Mo Kyung JUNG ; Seok Jin KANG ; Ahreum KWON ; Hyun Wook CHAE ; Ho Seong KIM ; Duk Hee KIM
Annals of Pediatric Endocrinology & Metabolism 2017;22(3):176-182
PURPOSE: Precocious puberty has significantly increased recently. While obesity is associated with puberty timing, the relationship between obesity and central precocious puberty (CPP) remains controversial. The purpose of this study was to determine whether insulin resistance is associated with bone age (BA) advancement in girls with CPP. METHODS: We retrospectively analyzed the records of 804 girls referred for puberty evaluation. Anthropometric measurements, BA, sex hormone, sex hormone binding globulin (SHBG), and insulin levels, lipid profiles, and gonadotropin releasing hormone stimulation tests were assessed. Insulin resistance parameters were calculated using the homeostasis model assessment-insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) models. RESULTS: BA, BA advancement, free estradiol index, insulin, and HOMA-IR increased significantly in girls with high body mass index (BMI) compared with that of girls with low BMI in cases of CPP. HOMA-IR was positively correlated with BA advancement and BMI but negatively correlated with SHBG. QUICKI was negatively correlated with BA advancement and BMI and positively correlated with SHBG. When HOMA-IR increased by 1, the odds for BA advancement increased 120% after adjusting for age and BMI (P=0.033). CONCLUSION: Insulin resistance could be associated with BA advancement in girls with CPP.
Adolescent
;
Body Mass Index
;
Estradiol
;
Female*
;
Gonadotropin-Releasing Hormone
;
Homeostasis
;
Humans
;
Insulin Resistance*
;
Insulin*
;
Luteinizing Hormone
;
Obesity
;
Puberty
;
Puberty, Precocious*
;
Retrospective Studies
;
Sex Hormone-Binding Globulin
6.Clinical manifestations of Rathke’s cleft cysts and their natural progression during 2 years in children and adolescents.
Jo Eun JUNG ; Juhyun JIN ; Mo Kyung JUNG ; Ahreum KWON ; Hyun Wook CHAE ; Duk Hee KIM ; Ho Seong KIM
Annals of Pediatric Endocrinology & Metabolism 2017;22(3):164-169
PURPOSE: Rathke’s cleft cyst (RCC) is an asymptomatic benign lesion. With increased interest in pediatric endocrinology, the prevalence of RCCs in children is also increasing. However, the clinical relevance and proper management of RCC is not well defined in children. Therefore, we investigated the clinical manifestations and radiologic features of RCC in children and adolescents, as well as the natural progression of RCC. METHODS: We retrospectively reviewed the medical records of 91 children and adolescents with RCC diagnosed with magnetic resonance imaging (MRI) in Severance Children’s Hospital from January 2006 to December 2015. The clinical, hormonal, and imaging findings were analyzed in patient groups classified according to age. The size of each cyst was assessed in sixty patients who underwent follow-up MRI during the 2 years. RESULTS: Female patients were predominant (64 vs. 27). The common clinical features at presentation were endocrine dysfunction (59.3%), headache (23.0%), and dizziness (4.4%). Symptoms related to endocrine disorders were more frequent in younger patients. In 7 patients managed surgically, the cysts were significantly larger and more frequently located in the suprasellar region. Of 60 nonsurgical patients with a follow-up MRI performed within 2 years after the diagnosis, the RCC size increased in about 26.7% (n=16). CONCLUSION: Although 94.4% of the patients with RCC had clinical symptoms, surgery was performed in only about 7.5% of patients. RCC is associated with pituitary insufficiency, thus, baseline and follow-up endocrine function tests are required. Additionally, regular MRI follow-up is required in long-term period to monitor change in size.
Adolescent*
;
Central Nervous System Cysts
;
Child*
;
Diagnosis
;
Dizziness
;
Endocrine System Diseases
;
Endocrinology
;
Female
;
Follow-Up Studies
;
Headache
;
Humans
;
Hypopituitarism
;
Magnetic Resonance Imaging
;
Medical Records
;
Natural History
;
Prevalence
;
Retrospective Studies
7.Diabetes mellitus due to agenesis of the dorsal pancreas in a patient with heterotaxy syndrome.
Jo Eun JUNG ; Jin Ho HUR ; Mo Kyung JUNG ; Ahreum KWON ; Hyun Wook CHAE ; Duk Hee KIM ; Ho Seong KIM
Annals of Pediatric Endocrinology & Metabolism 2017;22(2):125-128
Heterotaxy syndrome (HS) is a congenital disorder resulting from an abnormal arrangement of visceral organs across the normal left-right axis in the embryonic period. HS is usually associated with multiple anomalies, including defects of the major cardiovascular system and the extracardiovascular system such as intestinal malrotation, abnormal lung lobulation, bronchus anomalies, and pancreatic dysplasia. Although pancreatic dysplasia is occasionally accompanied with HS, the occurrence of diabetes mellitus (DM) due to pancreatic dysplasia in HS is rarely reported. We here report a case involving 13-year-old girl with DM caused by agenesis of the dorsal pancreas and HS diagnosed on the basis of the presence of a double-outlet right ventricle with bilateral pulmonary stenosis and intestinal malrotation with duodenal cyst. Timely diagnosis and treatment with insulin improved glycemic control.
Adolescent
;
Bronchi
;
Cardiovascular System
;
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
;
Diabetes Mellitus*
;
Diagnosis
;
Double Outlet Right Ventricle
;
Female
;
Heterotaxy Syndrome*
;
Humans
;
Insulin
;
Lung
;
Pancreas*
;
Pulmonary Valve Stenosis
8.Incidence and Mortality after Distal Radius Fractures in Adults Aged 50 Years and Older in Korea.
Gi Doo KWON ; Sunmee JANG ; Ahreum LEE ; Chan Mi PARK ; Young Kyun LEE ; Tae Young KIM ; Ha Young KIM ; Eun Ji PARK ; Yong Chan HA
Journal of Korean Medical Science 2016;31(4):630-634
The purpose of this study was to assess the incidence and mortality of distal radius fracture among patients 50 years of age and older with diagnosis code (ICD10; S52.5, S52.6) and treatment code using a nationwide claims database from 2008 to 2012. All patients were followed using patient identification code to identify deaths. Standardized mortality ratios (SMRs) of distal radius fracture were calculated based on age and gender-specific rates in the entire Korean population. The number of distal radius fractures increased by 54.2% over the 5-year study (48,145 in 2008 and 74,240 in 2012). The incidence of distal radius fracture increased from 367.4/100,000 in 2008 to 474.1/100,000 in 2012. The cumulative mortality rate over the first 12 months after distal radius fracture was decreased from 2.0% (968/48,145) in 2008 to 1.4% (1,045/74,240) in 2012. The mean year mortality over 5 years in men (2.6%, 1,279/50,128) over the first 12 months was 1.7-times higher than in women (1.5%, 3,952/257,045). The mean of SMR of distal radius fracture at 1 year post-fracture was 1.45 in men and 1.17 in women. This study using a nationwide database demonstrates that the distal radius fractures are increasing with a decreasing mortality in Korea.
Aged
;
Aged, 80 and over
;
Databases, Factual
;
Female
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Radius Fractures/*diagnosis/epidemiology/mortality
;
Republic of Korea/epidemiology
;
Sex Distribution
;
Survival Analysis
9.A 1-month-old infant with chylomicronemia due to GPIHBP1 gene mutation treated by plasmapheresis.
Mo Kyung JUNG ; Juhyun JIN ; Hyun Ok KIM ; Ahreum KWON ; Hyun Wook CHAE ; Seok Jin KANG ; Duk Hee KIM ; Ho Seong KIM
Annals of Pediatric Endocrinology & Metabolism 2017;22(1):68-71
Chylomicronemia is a severe type of hypertriglyceridemia characterized by chylomicron accumulation that arises from a genetic defect in intravascular lipolysis. It requires urgent and proper management, because serious cases can be accompanied by pancreatic necrosis or persistent multiple organ failure. We present the case of a 1-month-old infant with chylomicronemia treated by plasmapheresis. His chylomicronemia was discovered incidentally when lactescent plasma was noticed during routine blood sampling during a hospital admission for fever and irritability. Laboratory investigation revealed marked triglyceridemia (>5,000 mg/dL) with high chylomicron levels. We therefore decided to perform a therapeutic plasmapheresis to prevent acute pancreatitis. Sequence analysis revealed a homozygous novel mutation in exon 4 of GPIHBP1: c.476delG (p.Gly159Alafs). Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) stabilizes the binding of chylomicrons near lipoprotein lipase and supports lipolysis. Mutations of GPIHBP1, the most recently discovered gene, can lead to severe hyperlipidemia and are known to make up only 2% of the monogenic mutations associated with chylomicronemia. The patient maintains mild hypertriglyceridemia without rebound after single plasmapheresis and maintenance fibrate medication so far. Here, we report an infant with chylomicronemia due to GPIHBP1 mutation, successfully treated by plasmapheresis.
Chylomicrons
;
Exons
;
Fever
;
Humans
;
Hyperlipidemias
;
Hypertriglyceridemia
;
Infant*
;
Infant, Newborn*
;
Lipolysis
;
Lipoprotein Lipase
;
Multiple Organ Failure
;
Necrosis
;
Pancreatitis
;
Plasma
;
Plasmapheresis*
;
Sequence Analysis
10.Respiratory failure in a diabetic ketoacidosis patient with severe hypophosphatemia.
Han Saem CHOI ; Ahreum KWON ; Hyun Wook CHAE ; Junghwan SUH ; Duk Hee KIM ; Ho Seong KIM
Annals of Pediatric Endocrinology & Metabolism 2018;23(2):103-106
Phosphate is essential in regulating human metabolic processes, and severe hypophosphatemia can induce neurologic and hematological complications and result in respiratory failure and cardiac dysfunction. Therefore, correction of severe hypophosphatemia can be pivotal in the management of diabetic ketoacidosis (DKA). We report the case of a 14-year-old female who was diagnosed with type 1 diabetes and referred to our institute for treatment of DKA. Although the patient received fluid and continuous insulin administration according to the current DKA treatment protocol, generalized tonic seizures and cardiac arrest developed. After cardiopulmonary resuscitation, the patient recovered and was stable. Within 16 hours after DKA treatment, the patient developed respiratory failure with severe hypophosphatemia that required mechanical ventilation. Concurrent neurologic evaluation revealed no specific abnormalities. The patient recovered without any complications after correcting the hypophosphatemia. We suggest vigilant monitoring of the phosphate level in DKA patients and active replacement when required.
Adolescent
;
Cardiopulmonary Resuscitation
;
Clinical Protocols
;
Diabetic Ketoacidosis*
;
Female
;
Heart Arrest
;
Humans
;
Hypophosphatemia*
;
Insulin
;
Metabolism
;
Respiration, Artificial
;
Respiratory Insufficiency*
;
Seizures